年単位の研究成果
研究成果 1996 2019
2018
Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102) (International Journal of Clinical Oncology, (2016), 21, 4, (705-712), 10.1007/s10147-015-0943-z)
Miyamoto, Y., Tsuji, A., Tanioka, H., Maekawa, S., Kawanaka, H., Kitazono, M., Oki, E., Emi, Y., Murakami, H., Ogata, Y., Saeki, H., Shimokawa, M., Natsugoe, S., Akagi, Y., Baba, H. & Maehara, Y., 4 1 2018, : : International Journal of Clinical Oncology. 23, 2, 1 p.研究成果: ジャーナルへの寄稿 › コメント/討論
oxaliplatin
irinotecan
Medical Oncology
Colorectal Neoplasms
Japan
Erratum to: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition (Nature Medicine, (2018), 24, 7, (968-977), 10.1038/s41591-018-0022-x)
Wong, G. S., Zhou, J., Bin Liu, J., Wu, Z., Xu, X., Li, T., Xu, D., Schumacher, S. E., Puschhof, J., McFarland, J., Zou, C., Dulak, A., Henderson, L., Xu, P., O’Day, E., Rendak, R., Liao, W. L., Cecchi, F., Hembrough, T., Schwartz, S. および18人, , 10 1 2018, : : Nature medicine. 24, 10, 1 p.研究成果: ジャーナルへの寄稿 › コメント/討論
Mitogen-Activated Protein Kinase Kinases
Medicine
Actins
Neoplasms
2017
1
引用
(Scopus)
Erratum: Correction: Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution (PLoS genetics (2016) 12 2 (e1005778))
Uchi, R., Takahashi, Y., Niida, A., Shimamura, T., Hirata, H., Sugimachi, K., Sawada, G., Iwaya, T., Kurashige, J., Shinden, Y., Iguchi, T., Eguchi, H., Chiba, K., Shiraishi, Y., Nagae, G., Yoshida, K., Nagata, Y., Haeno, H., Yamamoto, H., Ishii, H. および21人, , 5 1 2017, : : PLoS genetics. 13, 5, p. e1006798研究成果: ジャーナルへの寄稿 › コメント/討論
公開
Molecular Evolution
colorectal neoplasms
Colorectal Neoplasms
cancer
Demography
Erratum to: Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: results of a multicenter, randomized, prospective, phase II clinical trial (Surgery Today, (2017), 47, 9, (1060-1071), 10.1007/s00595-017-1480-3)
Maehara, Y., Shirabe, K., Kohnoe, S., Emi, Y., Oki, E., Kakeji, Y., Baba, H., Ikeda, M., Kobayashi, M., Takayama, T., Natsugoe, S., Haraguchi, M., Yoshida, K., Terashima, M., Sasako, M., Yamaue, H., Kokudo, N., Uesaka, K., Uemoto, S., Kosuge, T. および9人, , 12 1 2017, : : Surgery today. 47, 12, p. 1539-1540 2 p.研究成果: ジャーナルへの寄稿 › コメント/討論
Surgical Wound Infection
Phase II Clinical Trials
Sutures
Publications
2015
Erratum to Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: Results of a multicenter study [Oncotarget., 6 (2015) 34004-34013]
Baba, H., Baba, Y., Uemoto, S., Yoshida, K., Saiura, A., Watanabe, M., Maehara, Y., Oki, E., Ikeda, Y., Matsuda, H., Yamamoto, M., Shimada, M., Taketomi, A., Unno, M., Sugihara, K., Ogata, Y., Eguchi, S., Kitano, S., Shirouzu, K., Saiki, Y. および5人, , 1 1 2015, : : Oncotarget. 6, 36, 1 p.研究成果: ジャーナルへの寄稿 › コメント/討論
Multicenter Studies
Colorectal Neoplasms
Drug Therapy
Messenger RNA
Erratum to Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002) (Ann Surg Oncol, (2015), 10.1245/s10434-015-4771-1)
Oki, E., Emi, Y., Miyamoto, Y., Kabashima, A., Higashi, H., Ogata, Y., Ikebe, M., Saeki, H., Tokunaga, S., Shirabe, K., Beppu, T., Uchida, S., Takatsuki, M., Sakoda, M., Eguchi, S., Akagi, Y., Kakeji, Y., Baba, H., Natsugoe, S. & Maehara, Y., 12 1 2015, : : Annals of Surgical Oncology. 22, 1 p.研究成果: ジャーナルへの寄稿 › コメント/討論
3
引用
(Scopus)
Intensive immunofluorescence staining methods for low expression protein: Detection of intestinal stem cell marker LGR5
Yamazaki, M., Kato, A., Zaitsu, Y., Watanabe, T., Iimori, M., Funahashi, S., Kitao, H., Saeki, H., Oki, E. & Suzuki, M., 10 29 2015, : : Acta Histochemica et Cytochemica. 48, 5, p. 159-164 6 p.研究成果: ジャーナルへの寄稿 › コメント/討論
Stem cells
Fluorescent Antibody Technique
Stem Cells
Staining and Labeling
Proteins
2014
Erratum to: Rad51 Expression Is a Useful Predictive Factor for the Efficacy of Neoadjuvant Chemoradiotherapy in Squamous Cell Carcinoma of the Esophagus [Ann Surg Oncol, 10.1245/S10434-013-3220-2]
Nakanoko, T., Saeki, H., Morita, M., Nakashima, Y., Ando, K., Oki, E., Ohga, T., Kakeji, Y., Toh, Y. & Maehara, Y., 11 19 2014, : : Annals of Surgical Oncology. 21, 4, 1 p.研究成果: ジャーナルへの寄稿 › コメント/討論